Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial motility and biofilm formation machinery refers to the integrated systems of appendages, signaling molecules, and extracellular components that allow bacteria to navigate environments and establish resilient communities (Kearns, 2010; Römling et al., 2013). Motility is often driven by flagella or pili, which are essential for the initial stages of surface colonization and host tissue invasion (Hall-Stoodley et al., 2004). Once attached, bacteria utilize quorum sensing and secondary messengers like cyclic-di-GMP to transition into a biofilm state, characterized by the production of a protective extracellular polymeric substance (EPS) matrix (Flemming & Wingender, 2010). This matrix acts as a physical barrier, contributing significantly to the high levels of antibiotic tolerance and immune evasion observed in chronic infections such as cystic fibrosis and catheter-associated urinary tract infections (Kostakioti et al., 2013). Therapeutic targeting of these processes, known as anti-virulence strategies, aims to disarm the bacteria by inhibiting adhesion, disrupting cell-to-cell communication, or promoting biofilm dispersal, thereby making the pathogens more susceptible to the host immune response and conventional antimicrobial agents (Dickey et al., 2017).
Anti-virulence mechanisms including competitive antagonism of adhesins (e.g., FimH), disruption of iron-dependent biofilm development, inhibition of quorum sensing receptors (e.g., LasR), and enzymatic degradation of the extracellular matrix.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial motility and biofilm formation machinery.